Pathik Shah¹, Harsh Gandhi^2*

¹Department of Internal Medicine, GMERS Medical College, Gotri, Vadodara, Gujarat, INDIA.

²Department of Internal Medicine, Baroda Medical College, Vadodara, Gujarat, INDIA.

Email: harshgandhi345@gmail.com

REFERENCES

1. Moyamoya Disease and Moyamoya Syndrome, R. Michael Scott and Edward R. Smith, New England Journal of Medicine, 360:1226-1237, March 19, 2009
2. Jump up to:a b 13. Ganesan, V., and Smith, E. R. (2015). Moyamoya: defining current knowledge gaps. Developmental Medicine and Child Neurology, 57(9), 786-787. doi:10.1111/dmcn.12708
3. Kleinloog, R (May 2012). "Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review". J Neurol Neurosurg Psychiatry. 83(5):531-6.
4. Duan, L (October 2011). "Moyamoya disease in China: its clinical features and outcomes". Stroke.
5. Janda, Paul; Bellew, Jonathan; Veerappan, Venkatachalam (2009). "Moyamoya disease: case report and literature review". The Journal of the American Osteopathic Association. 109 (10): 547–553. PMID 19861596.
6. Kuriyama S, Kusaka Y, Fujimura M, et al. (2008). "Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey". Stroke. 39 (1): 42–7. doi:10.1161/STROKEAHA.107.490714. PMID 18048855